These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Cooperation between physicians and pharmaceutical consultants. A questionnaire study]. Husby T Tidsskr Nor Laegeforen; 1991 Sep; 111(22):2758-60. PubMed ID: 1948870 [TBL] [Abstract][Full Text] [Related]
3. [Pharmaceutical consultants and drug information]. Kormeset PO Tidsskr Nor Laegeforen; 2008 Aug; 128(15):1684-5. PubMed ID: 18704147 [No Abstract] [Full Text] [Related]
4. The GP, the rep and the handouts. Seidel WF S Afr Med J; 1999 May; 89(5):520-3. PubMed ID: 10416451 [No Abstract] [Full Text] [Related]
5. Digoxin-related pharmacist-physician communications in a long-term facility: their acceptance and effects. Pink LA; Cooper JW; Francis WR Nurs Homes; 1985; 34(1):25-30. PubMed ID: 10283978 [No Abstract] [Full Text] [Related]
6. Interaction between physicians and the pharmaceutical industry. Arkinstall WW CMAJ; 1995 Aug; 153(4):398-9. PubMed ID: 7634216 [No Abstract] [Full Text] [Related]
8. [Pharmaceutical consultants don't give neutral information]. Reseland S Tidsskr Nor Laegeforen; 2008 Nov; 128(22):2620. PubMed ID: 19023368 [No Abstract] [Full Text] [Related]
9. [Physicians' contact with the drug industry. An interview among general practitioners]. Husby T; Tertnes AD; Skuseth G Tidsskr Nor Laegeforen; 1990 Apr; 110(10):1237-9. PubMed ID: 2333651 [TBL] [Abstract][Full Text] [Related]
10. Ethics, profit and patients: when pharmaceutical companies sponsor medical meetings. Barton L J Hosp Mark; 1993; 8(1):71-82. PubMed ID: 10135504 [TBL] [Abstract][Full Text] [Related]
11. Influence of attitudes, normative beliefs, and situational variables on physicians' use of pharmacists as drug information consultants. Fisher DJ; Pathak DS Am J Hosp Pharm; 1980 Apr; 37(4):483-91. PubMed ID: 7377210 [TBL] [Abstract][Full Text] [Related]
12. [The pharmaceutical consultant plays a principal role in the industry's information]. Klein S Nord Med; 1978 Apr; 93(3-4):84-5. PubMed ID: 643538 [No Abstract] [Full Text] [Related]
13. How good is communication between primary care physicians and subspecialty consultants? McPhee SJ; Lo B; Saika GY; Meltzer R Arch Intern Med; 1984 Jun; 144(6):1265-8. PubMed ID: 6732382 [TBL] [Abstract][Full Text] [Related]
14. [Medication on the threshold. Communication between physician and drug industry]. Everse JW Ned Tijdschr Geneeskd; 1969 Oct; 113(41):1778-84. PubMed ID: 5344633 [No Abstract] [Full Text] [Related]
15. Making the move into drug sales. Willerroider M Nature; 2004 Jul; 430(6998):486-7. PubMed ID: 15269778 [No Abstract] [Full Text] [Related]
16. Marketing pharmaceutical products to physicians. Sales reps influence physicians' impressions of the industry. Creyer EH; Hrsistodoulakis I Mark Health Serv; 1998; 18(2):34-8. PubMed ID: 10180333 [TBL] [Abstract][Full Text] [Related]
18. General practitioners and pharmacists interprofessional communication. Ruth D; Constable V; Daffey J; Dammery D; Hodge MM; Hogan C; Liddell M; Lloyd A Aust Fam Physician; 1994 Aug; 23(8):1544-6. PubMed ID: 7980154 [TBL] [Abstract][Full Text] [Related]
19. [Surgical congresses--are there too many? From the viewpoint of the Federal Association of the Pharmaceutical Industry]. Vogel HR Chirurg; 1995 Feb; 66(2):suppl 32-4. PubMed ID: 7712849 [No Abstract] [Full Text] [Related]
20. So much time for so little: Italy's pharmaceutical industry and doctors' information needs. Maestri E; Furlani G; Suzzi F; Campomori A; Formoso G; Magrini N BMJ; 2000 Jan; 320(7226):55-6. PubMed ID: 10617540 [No Abstract] [Full Text] [Related] [Next] [New Search]